Inhibiting GSDMD could prevent excessive inflammatory damage associated with pyroptosis, potentially offering therapeutic benefits in conditions like COPD, where inflammation plays a central role in disease progression [115]. This evidence concerns the gene GSDMD and chronic obstructive pulmonary disease.